The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antibody Discovery Services Market Research Report 2024

Global Antibody Discovery Services Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1893331

No of Pages : 107

Ask Your Query
Synopsis
Antibody discovery services are specialized laboratory services that focus on the identification and development of novel antibodies for various applications. These services use advanced techniques such as hybridoma technology, phage display, or single-cell sequencing to generate antibodies that specifically target desired antigens or proteins. Typically, they involve screening of large antibody libraries, antibody engineering, and optimization to enhance binding affinity and functional characteristics.
The global Antibody Discovery Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for antibody discovery services is towards increasing demand for high-quality and innovative antibodies that can address the growing need for personalized and precision medicine. With the advancements in biotechnology and computational biology, antibody discovery services are becoming more efficient and effective, leading to the development of more targeted and effective therapeutic strategies. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the need for more advanced antibody discovery capabilities, thus contributing to the growth of this industry trend.
This report aims to provide a comprehensive presentation of the global market for Antibody Discovery Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Discovery Services.
Report Scope
The Antibody Discovery Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Discovery Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Discovery Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocytogen
Charles River Laboratories
Abcam
Alloy Therapeutics
Creative Biolabs
Twist Bioscience
Rapid Novor
Curia
AlivaMab Biologics
Integrated DNA Technologies
Antibody Solutions
Eurofins Discovery
GenScript
Evotec
Aurigene Pharmaceutical Services
Yumab
Creative Bioarray
CD ComputaBio
Biomolecular Discovery Services
ProteoGenix
Sichuan NB Biolab
Viva Biotech
SAFE Pharmaceutical Technology
Shanghai Medicilon
WuXi Biologics
XtalPi
Detaibio
Cusabio
Segment by Type
Discovery of CAR-T Antibody Drugs
Discovery of Monoclonal Antibody Drugs
Discovery of ADC Antibody Drugs
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Discovery Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Discovery Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Discovery of CAR-T Antibody Drugs
1.2.3 Discovery of Monoclonal Antibody Drugs
1.2.4 Discovery of ADC Antibody Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibody Discovery Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Discovery Services Market Perspective (2019-2030)
2.2 Antibody Discovery Services Growth Trends by Region
2.2.1 Global Antibody Discovery Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Discovery Services Historic Market Size by Region (2019-2024)
2.2.3 Antibody Discovery Services Forecasted Market Size by Region (2025-2030)
2.3 Antibody Discovery Services Market Dynamics
2.3.1 Antibody Discovery Services Industry Trends
2.3.2 Antibody Discovery Services Market Drivers
2.3.3 Antibody Discovery Services Market Challenges
2.3.4 Antibody Discovery Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Discovery Services Players by Revenue
3.1.1 Global Top Antibody Discovery Services Players by Revenue (2019-2024)
3.1.2 Global Antibody Discovery Services Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Discovery Services Revenue
3.4 Global Antibody Discovery Services Market Concentration Ratio
3.4.1 Global Antibody Discovery Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Discovery Services Revenue in 2023
3.5 Antibody Discovery Services Key Players Head office and Area Served
3.6 Key Players Antibody Discovery Services Product Solution and Service
3.7 Date of Enter into Antibody Discovery Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Discovery Services Breakdown Data by Type
4.1 Global Antibody Discovery Services Historic Market Size by Type (2019-2024)
4.2 Global Antibody Discovery Services Forecasted Market Size by Type (2025-2030)
5 Antibody Discovery Services Breakdown Data by Application
5.1 Global Antibody Discovery Services Historic Market Size by Application (2019-2024)
5.2 Global Antibody Discovery Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Discovery Services Market Size (2019-2030)
6.2 North America Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Discovery Services Market Size by Country (2019-2024)
6.4 North America Antibody Discovery Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Discovery Services Market Size (2019-2030)
7.2 Europe Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Discovery Services Market Size by Country (2019-2024)
7.4 Europe Antibody Discovery Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Discovery Services Market Size (2019-2030)
8.2 Asia-Pacific Antibody Discovery Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Discovery Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Discovery Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Discovery Services Market Size (2019-2030)
9.2 Latin America Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Discovery Services Market Size by Country (2019-2024)
9.4 Latin America Antibody Discovery Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Discovery Services Market Size (2019-2030)
10.2 Middle East & Africa Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Discovery Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Discovery Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocytogen
11.1.1 Biocytogen Company Detail
11.1.2 Biocytogen Business Overview
11.1.3 Biocytogen Antibody Discovery Services Introduction
11.1.4 Biocytogen Revenue in Antibody Discovery Services Business (2019-2024)
11.1.5 Biocytogen Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Antibody Discovery Services Introduction
11.2.4 Charles River Laboratories Revenue in Antibody Discovery Services Business (2019-2024)
11.2.5 Charles River Laboratories Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Discovery Services Introduction
11.3.4 Abcam Revenue in Antibody Discovery Services Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Alloy Therapeutics
11.4.1 Alloy Therapeutics Company Detail
11.4.2 Alloy Therapeutics Business Overview
11.4.3 Alloy Therapeutics Antibody Discovery Services Introduction
11.4.4 Alloy Therapeutics Revenue in Antibody Discovery Services Business (2019-2024)
11.4.5 Alloy Therapeutics Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Detail
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Antibody Discovery Services Introduction
11.5.4 Creative Biolabs Revenue in Antibody Discovery Services Business (2019-2024)
11.5.5 Creative Biolabs Recent Development
11.6 Twist Bioscience
11.6.1 Twist Bioscience Company Detail
11.6.2 Twist Bioscience Business Overview
11.6.3 Twist Bioscience Antibody Discovery Services Introduction
11.6.4 Twist Bioscience Revenue in Antibody Discovery Services Business (2019-2024)
11.6.5 Twist Bioscience Recent Development
11.7 Rapid Novor
11.7.1 Rapid Novor Company Detail
11.7.2 Rapid Novor Business Overview
11.7.3 Rapid Novor Antibody Discovery Services Introduction
11.7.4 Rapid Novor Revenue in Antibody Discovery Services Business (2019-2024)
11.7.5 Rapid Novor Recent Development
11.8 Curia
11.8.1 Curia Company Detail
11.8.2 Curia Business Overview
11.8.3 Curia Antibody Discovery Services Introduction
11.8.4 Curia Revenue in Antibody Discovery Services Business (2019-2024)
11.8.5 Curia Recent Development
11.9 AlivaMab Biologics
11.9.1 AlivaMab Biologics Company Detail
11.9.2 AlivaMab Biologics Business Overview
11.9.3 AlivaMab Biologics Antibody Discovery Services Introduction
11.9.4 AlivaMab Biologics Revenue in Antibody Discovery Services Business (2019-2024)
11.9.5 AlivaMab Biologics Recent Development
11.10 Integrated DNA Technologies
11.10.1 Integrated DNA Technologies Company Detail
11.10.2 Integrated DNA Technologies Business Overview
11.10.3 Integrated DNA Technologies Antibody Discovery Services Introduction
11.10.4 Integrated DNA Technologies Revenue in Antibody Discovery Services Business (2019-2024)
11.10.5 Integrated DNA Technologies Recent Development
11.11 Antibody Solutions
11.11.1 Antibody Solutions Company Detail
11.11.2 Antibody Solutions Business Overview
11.11.3 Antibody Solutions Antibody Discovery Services Introduction
11.11.4 Antibody Solutions Revenue in Antibody Discovery Services Business (2019-2024)
11.11.5 Antibody Solutions Recent Development
11.12 Eurofins Discovery
11.12.1 Eurofins Discovery Company Detail
11.12.2 Eurofins Discovery Business Overview
11.12.3 Eurofins Discovery Antibody Discovery Services Introduction
11.12.4 Eurofins Discovery Revenue in Antibody Discovery Services Business (2019-2024)
11.12.5 Eurofins Discovery Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript Antibody Discovery Services Introduction
11.13.4 GenScript Revenue in Antibody Discovery Services Business (2019-2024)
11.13.5 GenScript Recent Development
11.14 Evotec
11.14.1 Evotec Company Detail
11.14.2 Evotec Business Overview
11.14.3 Evotec Antibody Discovery Services Introduction
11.14.4 Evotec Revenue in Antibody Discovery Services Business (2019-2024)
11.14.5 Evotec Recent Development
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Company Detail
11.15.2 Aurigene Pharmaceutical Services Business Overview
11.15.3 Aurigene Pharmaceutical Services Antibody Discovery Services Introduction
11.15.4 Aurigene Pharmaceutical Services Revenue in Antibody Discovery Services Business (2019-2024)
11.15.5 Aurigene Pharmaceutical Services Recent Development
11.16 Yumab
11.16.1 Yumab Company Detail
11.16.2 Yumab Business Overview
11.16.3 Yumab Antibody Discovery Services Introduction
11.16.4 Yumab Revenue in Antibody Discovery Services Business (2019-2024)
11.16.5 Yumab Recent Development
11.17 Creative Bioarray
11.17.1 Creative Bioarray Company Detail
11.17.2 Creative Bioarray Business Overview
11.17.3 Creative Bioarray Antibody Discovery Services Introduction
11.17.4 Creative Bioarray Revenue in Antibody Discovery Services Business (2019-2024)
11.17.5 Creative Bioarray Recent Development
11.18 CD ComputaBio
11.18.1 CD ComputaBio Company Detail
11.18.2 CD ComputaBio Business Overview
11.18.3 CD ComputaBio Antibody Discovery Services Introduction
11.18.4 CD ComputaBio Revenue in Antibody Discovery Services Business (2019-2024)
11.18.5 CD ComputaBio Recent Development
11.19 Biomolecular Discovery Services
11.19.1 Biomolecular Discovery Services Company Detail
11.19.2 Biomolecular Discovery Services Business Overview
11.19.3 Biomolecular Discovery Services Antibody Discovery Services Introduction
11.19.4 Biomolecular Discovery Services Revenue in Antibody Discovery Services Business (2019-2024)
11.19.5 Biomolecular Discovery Services Recent Development
11.20 ProteoGenix
11.20.1 ProteoGenix Company Detail
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Antibody Discovery Services Introduction
11.20.4 ProteoGenix Revenue in Antibody Discovery Services Business (2019-2024)
11.20.5 ProteoGenix Recent Development
11.21 Sichuan NB Biolab
11.21.1 Sichuan NB Biolab Company Detail
11.21.2 Sichuan NB Biolab Business Overview
11.21.3 Sichuan NB Biolab Antibody Discovery Services Introduction
11.21.4 Sichuan NB Biolab Revenue in Antibody Discovery Services Business (2019-2024)
11.21.5 Sichuan NB Biolab Recent Development
11.22 Viva Biotech
11.22.1 Viva Biotech Company Detail
11.22.2 Viva Biotech Business Overview
11.22.3 Viva Biotech Antibody Discovery Services Introduction
11.22.4 Viva Biotech Revenue in Antibody Discovery Services Business (2019-2024)
11.22.5 Viva Biotech Recent Development
11.23 SAFE Pharmaceutical Technology
11.23.1 SAFE Pharmaceutical Technology Company Detail
11.23.2 SAFE Pharmaceutical Technology Business Overview
11.23.3 SAFE Pharmaceutical Technology Antibody Discovery Services Introduction
11.23.4 SAFE Pharmaceutical Technology Revenue in Antibody Discovery Services Business (2019-2024)
11.23.5 SAFE Pharmaceutical Technology Recent Development
11.24 Shanghai Medicilon
11.24.1 Shanghai Medicilon Company Detail
11.24.2 Shanghai Medicilon Business Overview
11.24.3 Shanghai Medicilon Antibody Discovery Services Introduction
11.24.4 Shanghai Medicilon Revenue in Antibody Discovery Services Business (2019-2024)
11.24.5 Shanghai Medicilon Recent Development
11.25 WuXi Biologics
11.25.1 WuXi Biologics Company Detail
11.25.2 WuXi Biologics Business Overview
11.25.3 WuXi Biologics Antibody Discovery Services Introduction
11.25.4 WuXi Biologics Revenue in Antibody Discovery Services Business (2019-2024)
11.25.5 WuXi Biologics Recent Development
11.26 XtalPi
11.26.1 XtalPi Company Detail
11.26.2 XtalPi Business Overview
11.26.3 XtalPi Antibody Discovery Services Introduction
11.26.4 XtalPi Revenue in Antibody Discovery Services Business (2019-2024)
11.26.5 XtalPi Recent Development
11.27 Detaibio
11.27.1 Detaibio Company Detail
11.27.2 Detaibio Business Overview
11.27.3 Detaibio Antibody Discovery Services Introduction
11.27.4 Detaibio Revenue in Antibody Discovery Services Business (2019-2024)
11.27.5 Detaibio Recent Development
11.28 Cusabio
11.28.1 Cusabio Company Detail
11.28.2 Cusabio Business Overview
11.28.3 Cusabio Antibody Discovery Services Introduction
11.28.4 Cusabio Revenue in Antibody Discovery Services Business (2019-2024)
11.28.5 Cusabio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock